Triple
T15921511
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Certificates of Suitability to the monographs of the European Pharmacopoeia |
E386103
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | pharmaceutical quality document |
C14088
|
CONCEPT FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: pharmaceutical quality document Context triple: [Certificates of Suitability to the monographs of the European Pharmacopoeia, instanceOf, pharmaceutical quality document]
-
A.
pharmaceutical drug
A pharmaceutical drug is a chemically defined substance or combination of substances administered to diagnose, treat, prevent, or alleviate disease or medical conditions in humans or animals.
-
B.
pharmaceutical law
Pharmaceutical law is the body of legal rules and regulations governing the research, development, approval, manufacturing, marketing, distribution, and use of drugs and medical products to ensure their safety, efficacy, and ethical oversight.
-
C.
European Pharmacopoeia certificate
chosen
A European Pharmacopoeia certificate is an official document issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance or product complies with the relevant monograph(s) of the European Pharmacopoeia.
-
D.
medicinal product
A medicinal product is a substance or combination of substances presented as having properties for treating or preventing disease in humans or animals, or administered with the aim of restoring, correcting, or modifying physiological functions or making a medical diagnosis.
-
E.
pharmaceutical excipient
A pharmaceutical excipient is an inactive substance formulated alongside the active ingredient of a medication to aid in its manufacturing, stability, delivery, and patient acceptability.
- F. None of above.
Provenance (1 batch)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d86da686e4819097cbf3b1fc2d881d |
completed | April 10, 2026, 3:25 a.m. |
Created at: April 10, 2026, 4:52 a.m.